Cargando…
骨髓增生异常综合征患者合并疾病的预后意义研究
OBJECTIVE: To discuss the impact of comorbidities on the outcomes of patients with MDS. METHODS: The clinical characteristics of 676 MDS patients with detailed comorbidities evaluations was analyzed retrospectively. RESULTS: There were 395/676 cases (58.4%) with comorbidities (group 1), 281/676 case...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342508/ https://www.ncbi.nlm.nih.gov/pubmed/25854461 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.03.005 |
Ejemplares similares
-
伴TP53基因异常骨髓增生异常综合征患者的临床特征及预后研究
Publicado: (2019) -
骨髓增生异常综合征RAS基因突变的分子学特征及预后意义
Publicado: (2020) -
红细胞分布宽度在骨髓增生异常综合征患者中的预后价值
Publicado: (2022) -
骨髓增生异常综合征患者去甲基化治疗后WT1 mRNA水平的变化及其预后意义
Publicado: (2019) -
298例骨髓增生异常综合征患者染色体核型与临床预后分析
Publicado: (2015)